AHA 2016 Scientific Sessions: The PIONEER AF-PCI Trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Gibson CM, Mehran R, Bode C, et al. An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention PIONEER AF-PCI. Paper presented at: American Heart Association Scientific Sessions 2016; November 12-16, 2016; New Orleans, LA.
- Dewilde WJ, Oirbans T, Verheugt FW, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013;381(9872):1107-1115.
Disclosure statements are available on the authors' profiles: